We know who manufactures prolanta...the trial isn’t over. An estimated date doesn’t need to be extended. Nobody is “lashing out” at shareholders. This is pure fabrication.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.